Related Experiment Video
Updated: Jul 15, 2025

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
Published on: September 16, 2015
Neurobiological mechanisms underlying psychostimulant use
Rianne R Campbell1, Mary Kay Lobo2
1Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: https://twitter.com/RianneThoughts.
Rates of psychostimulant use disorder (PSUD) are rising, yet no medications exist to aid abstinence. This review explores neurobiological mechanisms, including transcription and synaptic plasticity, crucial for developing new PSUD pharmacotherapeutics.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Psychostimulant use disorder (PSUD) is a growing public health concern with no approved pharmacotherapies.
- Chronic psychostimulant use alters brain functions related to decision-making, reward, and memory, driving compulsive drug-seeking behaviors.
Purpose of the Study:
- To review novel findings and theories on the neurobiological underpinnings of PSUD.
- To identify promising molecular and neural circuit mechanisms for developing new pharmacotherapeutics for PSUD.
Main Methods:
- This review synthesizes current research on psychostimulant effects on brain mechanisms.
- Focuses on molecular pathways (transcription, mitochondrial function) and neural circuitry (synaptic plasticity, network rewiring).
Main Results:
- Psychostimulants dysregulate transcription, mitochondrial function, and synaptic plasticity within the reward system.
- These alterations promote persistent craving and drug-seeking behaviors by rewiring neural networks.
- Evidence suggests specific molecular and circuit-level changes drive addiction-related behaviors.
Conclusions:
- Understanding the neurobiology of PSUD, particularly at the molecular and synaptic levels, is key to pharmacotherapeutic development.
- Targeting mechanisms like transcription, mitochondrial function, and synaptic plasticity offers promising avenues for novel PSUD treatments.
- Further research into these biological bases is critical for advancing addiction pharmacotherapy.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

